CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

18
CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP

Transcript of CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

Page 1: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

CLINICAL RESEARCH STUDIES

Janette Hannam, MS, CTRA

Asst. Director for Research, OSP

Page 2: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

WHY DO CLINICAL TRIALS?

• New patient treatments

• Further University research efforts

• Partnership with industry

• Increase research funding

• Opportunity for investigators to publish

Page 3: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

Sources of Sponsored Research$353,908,822

Foreign$1,211,912

State$2,705,230

University$22,397,225

Federal$256,701,835

Corporate$16,102,273

Private$54,790,347

Page 4: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

How do I get started?

• Route COMPLETE proposal to:• Human Investigations Committee

(HIC)• Office of Sponsored

Programs(OSP)

• DO NOT need HIC approval prior to routing to OSP!!

Page 5: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

WHAT DO I ROUTE?

• COMPLETE PROPOSAL consists of:– Sponsored Programs Approval Form(SPAF)– Protocol including informed consent and/

subject authorization– Budget– Clinical Trial Agreement– Name and phone numbers for company

contacts

Page 6: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

WHEN DO I ROUTE?

•YESTERDAY!!• When ALL documents are received

– The worse thing you can do is route an incomplete package

Page 7: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

WHY DO I ROUTE?

• To insure that ALL University authorities are in agreement with protocol/research that is being proposed.

Page 8: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

SPAFSponsored Programs Approval Form

• Why do I need a SPAF??– Indicates approval from:

• Supervisor

• Division Chief, if necessary

• Chair

• Dean, School of Medicine

• Office of Sponsored Programs

Page 9: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

PROTOCOL

• Purpose– Allows those approving protocol/research to

review what work is to be performed– Outlines specifically what will be done– Instructs all those working on project– Gives clinical contacts at company– Becomes document of record should litigation

occur

Page 10: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

BUDGET• Indicates how research funding is to be allocated• Gives Department and School benchmarks for

internal budget projections• Provides Office of Grants and Contracts

guidelines on receipts and expenses

• Supports legal contract • Shows indirect cost rate

Page 11: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

Clinical Trial Agreement

• Creates legal document between Company and University

• Gives clear definitions as to what Company and University have agreed to

• Must be executed by University official(OSP)

Page 12: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

Key Elements in CTA

• Recitals(who, what, when & where)

• Dates

• Dollars

• Indemnification

• Termination

• Confidentiality

• Publication

• Data Ownership

• License & Patents

• Legal Jurisdiction

Page 13: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

What is OSP’s involvement?• Negotiate language in clinical trial

agreement with company

• Execute documents on behalf of University

• Insure HIC compliance

• Act as liaison between University, Company, other University offices

• Coordinate documents

• Complete award process(account number)

Page 14: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

When can we see patients?

• All documents are signed

• OSP receives fully executed original clinical trial agreement

• HIC approval is obtained

• NOA is completed and sent to OGCA

Page 15: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

When do I get an account number?

• All documents are signed

• OSP receives fully executed original clinical trial agreement

• HIC is approved

• Office of Grants and Contracts has given account number to OSP

Page 16: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

When can I use the new account number?

• After OSP does Notice of Acceptance

• After OGCA inputs NOA information

Page 17: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

Why can’t the investigator sign clinical trial agreement?

• Not authorized by University to enter into contracts on behalf of University

• Insures compliance to policy and procedures

Page 18: CLINICAL RESEARCH STUDIES Janette Hannam, MS, CTRA Asst. Director for Research, OSP.

QUESTIONS